FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
SAN FRANCISCO, CA USA (UroToday.com) - Presented by Xu Steven Xu, Charles J. Ryan, Kim Stuyckens, Matthew R. Smith, Fred Saad, Thomas W. Griffin, Youn C. Park, Margaret K. Yu, An Vermeulen, Italo Poggesi, and Partha Nandy at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA
Janssen Research & Development, Raritan, NJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Janssen Research & Development, Beerse, Belgium; Harvard Medical School and Massachusetts General Hospital, Boston, MA; University of Montréal, Montréal, QC, Canada; Janssen Research & Development, Los Angeles, CA